Skip to content
Pureza
Tesamorelin, 10 mg, Pureza research material

GHRH analog

Tesamorelin

Tesamorelin is a stabilized analog of the 44-amino-acid human growth hormone-releasing hormone, modified with a trans-3-hexenoyl group at the N-terminus. In research models, it binds to the GHRH receptor in the anterior pituitary and acts on that signaling pathway. It has been studied in models of the somatotropic axis and adipose tissue distribution in preclinical research.

Select a variant

$3,040 MXN / unit

Mass: 10 mg

In stock · SKU TES-10

Prices in Mexican pesos. Cart and secure checkout are currently in Spanish. Shipping and any applicable discounts are shown before payment.

For laboratory research only. Not for human or veterinary use.

Shipping within Mexico · Free from $2,500 MXN.

Shipping protection included: report damage with photos within 24 hours of delivery for one replacement.

Shipping terms

Research context & mechanism

The GHRH receptor is a Gs protein-coupled receptor whose activation increases intracellular cyclic AMP in cellular models. The N-terminal modification reduces enzymatic degradation in in vitro studies.

Technical specifications

Reference specifications describe the material. They do not replace the analytical results for a specific batch.

Chemical name
Trans-3-hexenoyl-GHRH(1-44) amide
Sequence
Not available
Molecular formula
C221H366N72O67S
Molecular weight
5135.9 Da
CAS number
218949-48-5
Form
Lyophilized powder
Appearance
White to off-white solid
Purity specification
Declared in the batch certificate
Identity
Declared in the batch certificate
Solubility
Soluble in sterile water and bacteriostatic water
Storage
−20 °C, protected from light
Stability after reconstitution
Keep refrigerated at 2–8 °C and use within the period defined by the laboratory protocol

Batch documentation

Review documentation for the product and variant you are purchasing. A reference specification, a research publication and an individual batch certificate are different sources. Certificate results are accessed with your order details; if documentation is available on request, contact support before relying on it.

Consult batch certificates How to read documentation

Laboratory handling

Reconstitution
Laboratory procedure: allow the closed vial to reach room temperature, disinfect the septum and slowly transfer the diluent against the inner wall of the vial. Do not shake; gently swirl the vial until fully dissolved. Record the volume, diluent and date in the batch log.
Storage
Sealed vial of lyophilized material: store at −20 °C, protected from light and moisture. Avoid repeated freeze-thaw cycles of reconstituted material; aliquot when the experimental design permits.
Protective equipment
Handle in a clean work area with a lab coat, nitrile gloves and eye protection. Dispose of vials, tips and sharps according to the laboratory waste procedure.

Research references

  1. Metabolic effects of a growth hormone-releasing factor in patients with HIV.

    N Engl J Med · 2007 · PMID 18057338

  2. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.

    JAMA · 2014 · PMID 25038357

  3. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.

    Lancet HIV · 2019 · PMID 31611038

  4. Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials.

    Obes Res Clin Pract · 2026 · PMID 41545261

  5. Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects.

    Clin Pharmacokinet · 2015 · PMID 25358450

Frequently asked questions

How is Tesamorelin supplied?

Tesamorelin is supplied in a sealed vial containing the quantity indicated for the selected variant, with its batch identifier printed on the label.

How is Tesamorelin stored in the laboratory?

Store the closed vial at −20 °C, protected from light and moisture. See the laboratory handling section of this page for the complete procedure.

Related research materials